// App-Quantinova.ai

POS03 : Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice - Results of the ISAR-ABSORB Registry

Researchers

Presenter

  • Hoppmann P

Principal Investigators

  • Kufner S

  • Cassese S

  • Wiebe J

  • Schneider S

  • Bradaric C

  • Ibrahim T

  • Schunkert H

  • Laugwitz K-L

  • Kastrati A

  • Byrne R

Medical Centers

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Medizinische Klinik, Klinkum rects der Isar, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Multi-vessel disease

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved